Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 3019-3025

  Takano, Manabu ^a   Nishimura, Hitoshi ^a   Kimura, Yuki ^a   Washizu, Junji ^a   Mokuno, Yasujii ^a   Nimura, Yuji ^a   Yoshikai, Yasunobu ^a,b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ministry of Health Welfare of Japan

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYCLIC AMP; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 10; INTERLEUKIN 12; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HOST RESISTANCE; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; BLOOD; C3H MOUSE; CELL MOTION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; LIVER DISEASE; METABOLISM; MICROBIOLOGY; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CELL MOVEMENT; DINOPROSTONE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; MICE; MICE, INBRED C3H; PERITONEAL CAVITY; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032529847     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Arai, K. I., F. Lee, A. Miyajima, S. Miyatake, N. Arai, and T. Yokota. 1990. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:783.
2. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
3. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
4. Gantner, F., M. Leist, A. W. Lohse, P. G. Germann, and G. Tiegs. 1995. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21:190.
5. Mizuhara, T., E. O'Neil, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara. 1994. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by Interleukin 6. J. Exp. Med. 179:1529.
6. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF-α primary mediator of the host response. Annu. Rev. Immunol. 7:625.
7. Leist, M., F. Gantner, I. Bohlinger, P. G. Germann, G. Tiegs, and A. Wendel. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 153:1778.
8. Billiau, A. 1988. Gamma-interferon: the match that lights the fire? Immunol. Today 9:37.
9. Tanaka, Y., A. Takahashi, K. Watanabe, K. Takayama, T. Yahara, S. Habu, and T. Nishimura. 1996. A pivotal role of IL-12 in Th1-dependent mouse liver injury. Int. Immunol. 8:569.
10. Moore, K. W., A. O'Garra, R. W. Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
11. Tsunawaki, S., M. Sporn, A. Ding, and C. F. Nathan. 1988. Deactivation of macrophages by transforming growth factor β. Nature 334:260.
12. 2. Proc. Natl. Acad. Sci. USA 86:3803.
13. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
14. Louis, H., O. L. Moine, M.-O. Peny, B. Gulbis, F. Nisol, M. Goldman, and J. Devière. J. 1997. Hepatoprotective role of interleukin-10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology 112:935.
15. Arai, T., K. Hiromatsu, N. Kobayashi, M. Takano, H. Ishida, Y. Nimura, and Y. Yoshikai. 1995. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphates on endotoxin-induced inflammatory liver injury. J. Immunol. 155:5743.
16. 2 and cyclic nucleotides. J. Immunol. 141:2388.
17. Tannenbaum, C. S., and T. A. Hamilton. 1989. Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J. Immunol. 142:1274.
18. Muñoz, E., A. M. Zubiaga, M. Merrow, N. P. Sauter, and B. T. Huber. 1990. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:95.
19. Platzer, C., C. Meisel, K. Vogt, M. Platzer, and H.-D. Volk. 1995. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7:517.
20. Chandra, G., J. P. Cogswell, L. R. Miller, M. M. Godlevski, S. W. Stinnett, S. L. Noel, S. H. Kadwell, T. A. Kost, and J. G. Gray. 1995. Cyclic AMP signaling pathways are important in IL-1β transcriptional regulation. J. Immunol. 155:4535.
21. Inoue, H., S. Takahashi, K. Nomoto, and Y. Yoshikai. 1995. Dibutyryl cAMP protects Corynebacterium parvum-treated mice against lipopolysaccharide-induced lethal toxicity. Cell Immunol. 162:1.
22. Haraguchi, S., R. A. Good, and N. K. Day. 1995. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today 16:595.
23. Chen, D., and E. V. Rothenberg. 1994. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179:931.
24. Neumann, M., T. Grieshammer, S. Chuvpilo, B. Kneitz, M. Lohoff, A. Schimpl, B. R. Franza, Jr., and E. Serfling. 1995. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14:1991.
25. Tsuruta, L., H.-J. Lee, E. S. Masuda, N. Koyano-Nakagawa, N. Arai, K. Arai, and K. Yokota. 1995. Cyclic AMP inhibits expression of the IL-2 gene though the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP. J. Immunol. 154: 5255.
26. 2 is a potent inhibitor of human Interleukin 12 production. J. Exp. Med. 181:775.
27. Phipps, R. P., S. H. Stein, and R. L. Roper. 1991. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12:349.
28. 2. J. Exp. Med. 180:2365.
29. 2 regulates macrophage derived tumor necrosis factor gene expression. J. Biol. Chem. 263:5380.
30. 2. Biochem. Biophys. Res. Commun. 137:404.
31. Kammer, G. M. 1988. The adenylate cyclase-cAMP-protein kinase: a pathway and regulation of the immune response. Immunol. Today 9:222.
32. Sinclair, S. B., P. D. Greig, L. M. Blendis, M. Abecassis, E. A. Roberts, M. J. Phillips, R. Cameron, and G. A. Levy. 1989. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E: a preliminary report. J. Clin. Invest. 84:1063.
33. 2) in the treatment of fulminant hepatic failure (FHF). Hepatology 16(Suppl. 4):88a.
34. Albracht, C., D. K. F. Meijer, C. Lebbe, H. Sagesser, B. N. Melgert, K. Poelsta, and J. Reichen. Targeting naproxen coupled to human serum albumin to non-parenchymal cells reduces endotoxin-induced mortality in rats with biliary cirrhosis 1997. Hepatology 26:1553.
35. Haarbrecht, B. G., J. Stadler, A. J. Demetris, R. L. Simmons, and T. R. Billiar. 1994. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am. J.Physiol. 266:1004.
36. Fischer, W., C. Schudt, and A. Wendel. 1993. Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice. Biochem. Pharmacol. 45:2399.
37. Nagai, H., M. Aoli, T. Shimazawa, I. Yakuo, A. Koda, and M. Kasahara. 1989. Effect of OKY-046 and ONO-3708 on liver injury in mice. Jpn. J. Pharmacol. 51:191.
38. Takada, H., K. Hiromatsu, G. Matsuzaki, K. Muramori, and K. Nomoto. 1993. peritoneal γδ T cells induced by Escherichia coli infection in mice. J. Immunol. 151:2062.
39. Nakano, Y., K. Onozaki, Y. Takeda, H. Shinomiya, and M. Nakano. 1990. Protective effect of recombinant tumor necrosis factor-α in murine salmonellosis. J. Immunol. 144:1935.
40. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762.
41. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxin shock, yet succumb to L. monocytogenes infection. Cell 73:457.
42. Rothe J, W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor I are resistant to TNF-mediated cytotoxicity but are highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
43. Bogdan, C., Y. Vodovotz, and C. F. Nathan. 1991. Macrophage deactivation by Interleukin 10. J. Exp. Med. 74:1549.
44. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. Interleukin-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
45. Janis, E.M., S. H. E. Kaufmann, R. H. Schwartz, and D. M. Pardoll. 1989. Activation of γδ T cells in the primary immune response to Mycobacterium tuberculosis. Science 244:713.
46. Ohga, S., Y. Yoshikai, Y. Takeda, K. Hiromatsu, and K. Nomoto. 1990. Sequential appearance of γ/δ-and α/β-bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes. Eur. J. Immunol. 20:533.
47. Emoto, M., H. Danbara, and Y. Yoshikai. 1992. Induction of γ/δ T cells in murine salmonellosis by avirulent but not by a virulent strain of Salmonella choleraesuis. J. Exp. Med. 176:363.
48. Kaufmann, S. H. E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129.
49. Haas W., P. Pereira, and S. Tonegawa. 1993. Gamma/delta cells. Annu. Rev. Immunol. 11:637.
50. Hiromatsu, K., Y. Yoshikai, G. Matsuzaki, S. Ohga, K. Muramori, K. Matsumoto, J. A. Bluestone, and K. Nomoto. 1992. A protective role of γ/δ T cells in primary infection with Listeria monocytogenes in mice. J. Exp. Med. 175:49.
51. Ladel, C. H., C. Blum, A. Dreher, K. Reifenberg, and S. H. E. Kaufmann. 1995. Protective role of γ/δ T cells and α/β T cells in tuberculosis. Eur. J. Immunol. 25:2877.
52. Mombaerts, P., J. Amoldi, F. Russ, S. Tonegawa, and S. H. E. Kaufmann. 1993. Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen. Nature 365:53.
53. Tsuji, M., C. L. Eyster, R. L. O'Brien, W. K. Born, M. Bapna, M. R., R. S. Nussenzweig, and F. Zavala. 1995. Phenotypic and functional properties of murine γδ T cell clones derived from malaria-immunized, αβ T cell-deficient mice. Int. Immunol. 8:359.
54. Sciammas, R., P. Kodukula, Q. Tang, R. L. Hendricks, and J. A. Bluestone. 1997. T cell receptor-γ/δ cells protect mice from herpes simple virus type 1-induced lethal encephalitis. J. Exp. Med. 185:1969.
55. Ueta, C., H. Kawasumi, T. Fujiwara, T. Miyagama, H. Kida, Y. Ohmoto, S. Kishimoto, and I. Tsuyuguchi. 1996. Interleukin-12 activates human γδ T cells: synergistic effect of tumor necrosis factor α. Eur. J. Immunol. 26:3066.
56. + T cells while decreasing IL-2 release and NF-AT induction. Int. Immunol. 6:1333.
57. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108.
58. Novak, T. J., and E. V. Rothenberg. 1990. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87:9353.